呼吸系统疾病的分子机制、诊断与治疗
Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases.
作者信息
Shen Te-Chun
机构信息
School of Medicine, China Medical University, Taichung 404, Taiwan.
Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
出版信息
Biomedicines. 2024 Dec 24;13(1):4. doi: 10.3390/biomedicines13010004.
Abstract
The Special Issue "Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases" in the journal compiles critical advancements in the understanding of respiratory diseases, focusing on their molecular mechanisms, diagnostic approaches, and therapeutic strategies [...].
摘要
该期刊的“呼吸系统疾病的分子机制、诊断与治疗”特刊汇集了在呼吸系统疾病认识方面的关键进展，重点关注其分子机制、诊断方法和治疗策略[...]。
相似文献
1
Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases.呼吸系统疾病的分子机制、诊断与治疗
Biomedicines. 2024 Dec 24;13(1):4. doi: 10.3390/biomedicines13010004.
2
New Insights in Radiotherapy.放射治疗的新见解
Biomedicines. 2022 Aug 9;10(8):1931. doi: 10.3390/biomedicines10081931.
3
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成：药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
4
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.首届卡塔尔重症监护会议及其《卡塔尔医学杂志》特刊——一个重要的里程碑。
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
5
Women's Special Issue Series: Biomedicines.女性特刊系列：生物药物
Biomedicines. 2024 Feb 20;12(3):471. doi: 10.3390/biomedicines12030471.
6
Precision medicine for respiratory diseases: A current viewpoint.呼吸系统疾病的精准医学：当前观点
Med Int (Lond). 2024 Apr 12;4(4):31. doi: 10.3892/mi.2024.155. eCollection 2024 Jul-Aug.
7
Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches.神经发育障碍：从病理生理学到新型治疗方法
Biomedicines. 2022 Mar 7;10(3):623. doi: 10.3390/biomedicines10030623.
8
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models.通过体外实验模型揭示慢性呼吸道疾病潜在的分子机制，以开发新型治疗方法。
Eur J Pharmacol. 2022 Mar 15;919:174821. doi: 10.1016/j.ejphar.2022.174821. Epub 2022 Feb 11.
9
Parasitic Infection and Immunity-A Special Biomedicines Issue.寄生虫感染与免疫——生物医学特刊
Biomedicines. 2022 Oct 12;10(10):2547. doi: 10.3390/biomedicines10102547.
10
Respiratory diseases call for special attention from clinical and translational science.呼吸系统疾病需要临床和转化科学给予特别关注。
Transl Respir Med. 2013 Dec;1(1):1. doi: 10.1186/2213-0802-1-1. Epub 2013 Feb 22.
本文引用的文献
1
Cystic fibrosis.囊性纤维化。
Nat Rev Dis Primers. 2024 Aug 8;10(1):53. doi: 10.1038/s41572-024-00538-6.
2
Bronchiectasis.支气管扩张症
Open Respir Arch. 2024 May 29;6(3):100339. doi: 10.1016/j.opresp.2024.100339. eCollection 2024 Jul-Sep.
3
Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives.探讨 COPD 的分子机制和生物标志物：当前进展和展望概述。
Int J Mol Sci. 2024 Jul 4;25(13):7347. doi: 10.3390/ijms25137347.
4
Phenotypes in pulmonary hypertension.肺动脉高压的表型。
Eur Respir J. 2024 Sep 5;64(3). doi: 10.1183/13993003.01633-2023. Print 2024 Sep.
5
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.广泛期小细胞肺癌免疫治疗的分子分类和预后标志物：CASPIAN 三期研究分析。
Mol Cancer. 2024 May 30;23(1):115. doi: 10.1186/s12943-024-02014-x.
6
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU.从 ICU 综合征到 ICU 亚表型：精准医学在 ICU 中的发展共识报告和建议。
Am J Respir Crit Care Med. 2024 Jul 15;210(2):155-166. doi: 10.1164/rccm.202311-2086SO.
7
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.长新冠的已知与未知：从发病机制到治疗方法。
Front Immunol. 2024 Mar 4;15:1344086. doi: 10.3389/fimmu.2024.1344086. eCollection 2024.
8
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.新型冠状病毒肺炎中血管内皮激活、高凝和血栓形成的机制：与糖尿病的关联。
Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8.
9
Malignant pleural effusion: current understanding and therapeutic approach.恶性胸腔积液：当前的认识和治疗方法。
Respir Res. 2024 Jan 19;25(1):47. doi: 10.1186/s12931-024-02684-7.
10
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma.基于人工智能的模型 ANORAK 可提高肺腺癌的组织病理学分级。
Nat Cancer. 2024 Feb;5(2):347-363. doi: 10.1038/s43018-023-00694-w. Epub 2024 Jan 10.
Zotero 插件